Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence
- 23 March 2010
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 21 (9) , 1751-1755
Abstract
Specific Aim: To review the evidence indicating that volumetric image analysis of computed tomography scans meets specifications for qualification as a biomarker in clinical trials or the management of individual patients with lung cancer. Methods: Claims of value were broken down into questions about technical feasibility, accuracy, the precision of measurement, sensitivity, the correlations with health outcomes, and the risks of producing misleading information. For each claim, the pertinent literature was reviewed. Results: Technical feasibility has now been shown, but only in limited contexts. Accuracy has been demonstrated, but only for tumors with favorable anatomical features. Measurement error still makes the assessment of change in small nodules precarious in diagnostic settings unless rigorous image acquisition and analysis procedures are followed. Precision is sufficient in some larger masses to make volumetrics a sensitive biomarker. In a few trials, correlations with clinical outcomes have been higher for volumetric-based measures than for unidimensional or bidimensional diameters. Value in clinical practice settings and clinical trials has been suggested, but not proven. Conclusion: The weight of the evidence indicates there are circumstances in which volumetric image analysis adds value to clinical trial science and the practice of medicine.Keywords
This publication has 36 references indexed in Scilit:
- Noncalcified Lung Nodules: Volumetric Assessment with Thoracic CTRadiology, 2009
- Considerations for the Use of Imaging Tools for Phase II Treatment Trials in OncologyClinical Cancer Research, 2009
- Imaging Surrogates of Tumor Response to Therapy: Anatomic and Functional BiomarkersJournal of Nuclear Medicine, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Radiologic Measurements of Tumor Response to Treatment: Practical Approaches and LimitationsRadioGraphics, 2008
- Measures of Response: RECIST, WHO, and New AlternativesJournal of Clinical Oncology, 2006
- Interobserver and Intraobserver Variability in the Assessment of Pulmonary Nodule Size on CT Using Film and Computer Display Methods1Academic Radiology, 2005
- Volumetric Assessment of Pulmonary Nodules with ECG-Gated MDCTAmerican Journal of Roentgenology, 2004
- Interobserver and Intraobserver Variability in Measurement of Non–Small-Cell Carcinoma Lung Lesions: Implications for Assessment of Tumor ResponseJournal of Clinical Oncology, 2003
- Value of computed tomography in radiotherapy of lung cancerAmerican Journal of Roentgenology, 1978